v3.25.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jul. 31, 2025
Apr. 30, 2025
Current assets:    
Cash and cash equivalents $ 124,304 $ 131,615
Marketable securities 67,161 89,002
Accounts receivable, net 1,926  
Research and development tax credit receivable 561 1,383
Prepaid expenses and other current assets 11,944 19,690
Total current assets 205,896 241,690
Property and equipment, net of accumulated depreciation of $4,925 and $4,747 2,067 1,988
Right of use assets 5,165 5,544
Other assets 2,377 1,548
Total assets 215,505 250,770
Current liabilities:    
Accounts payable 5,869 4,883
Accrued expenses 18,971 27,307
Lease liability - current portion 2,122 1,977
Deferred revenue 11,413 11,000
Total current liabilities 38,375 45,167
Long-term liabilities:    
Lease liability - net of current portion 4,019 4,330
Royalty obligation 132,321 105,882
Total long-term liabilities 136,340 110,212
Stockholders’ equity    
Common stock, $0.001 par value, 100,000,000 authorized Shares issued and outstanding: 50,339,823 at July 31, 2025 and 49,762,048 at April 30, 2025 50 50
Additional paid-in capital 760,393 753,725
Accumulated deficit (713,266) (653,170)
Accumulated other comprehensive loss (6,387) (5,214)
Total stockholders’ equity 40,790 95,391
Total liabilities and stockholders’ equity $ 215,505 $ 250,770